C. M. Appolinario and A. C. Jackson, Antiviral therapy for human rabies, Antivir. Ther, vol.20, pp.1-10, 2015.

R. Assenberg, O. Delmas, B. Morin, S. C. Graham, X. De-lamballerie et al., Genomics and structure/ function studies of Rhabdoviridae proteins involved in replication and transcription, Antivir. Res, vol.87, pp.149-161, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-01492926

D. A. Barkhouse, S. A. Garcia, E. K. Bongiorno, A. Lebrun, M. Faber et al., Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon, J. Virol, vol.89, pp.312-322, 2015.

Y. Ben-khalifa, S. Luco, B. Besson, F. Sonthonnax, M. Archambaud et al., The matrix protein of rabies virus binds to RelAp43 to modulate NF-?B-dependent gene expression related to innate immunity, Sci. Rep, vol.21, issue.6, p.39420, 2016.

H. Bourhy, M. Goudal, A. Mailles, M. Sadkowska-todys, L. Dacheux et al., Is there a need for anti-rabies vaccine and immunoglobulins rationing in Europe?, Euro Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull, vol.14, 2009.

H. Bourhy, A. Dautry-varsat, P. J. Hotez, and J. Salomon, Rabies, still neglected after 125 years of vaccination, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-01491946

K. Brzózka, S. Finke, and K. Conzelmann, Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2, 2006.

. Virol, , vol.80, pp.2675-2683

U. J. Buchholz, S. Finke, and K. K. Conzelmann, Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter, J. Virol, vol.73, pp.251-259, 1999.

F. Bussereau, M. Picard, J. Blancou, and P. Sureau, Treatment of rabies in mice and foxes with antiviral compounds, Acta Virol, vol.32, pp.33-49, 1988.

I. C. Bygbjerg, Pyrimethamine-induced alterations in human lymphocytes in vitro. Mechanisms and reversal of the effect, Acta Pathol. Microbiol. Immunol. Scand, vol.93, pp.183-188, 1985.

I. C. Bygbjerg, M. Svenson, T. G. Theander, and K. Bendtzen, Effect of antimalarial drugs on stimulation and interleukin 2 production of human lymphocytes, Int. J. Immunopharm, vol.9, pp.513-519, 1987.

M. K. Chelbi-alix, A. Vidy, J. El-bougrini, and D. Blondel, Rabies viral mechanisms to escape the IFN system: the viral protein P interferes with IRF-3, Stat1, and PML nuclear bodies, J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res, vol.26, pp.271-280, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00091617

Y. Chen, Z. Yin, S. B. Lakshminarayana, M. Qing, W. Schul et al., Inhibition of dengue virus by an ester prodrug of an adenosine analog, Antimicrob. Agents Chemother, vol.54, pp.3255-3261, 2010.

D. Chopy, C. N. Detje, M. Lafage, U. Kalinke, and M. Lafon, The type I interferon response bridles rabies virus infection and reduces pathogenicity, J. Neurovirol, vol.17, pp.353-367, 2011.

T. Chou, Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies, Pharmacol. Rev, vol.58, pp.621-681, 2006.

M. G. Corral, J. Leroux, K. A. Stubbs, and J. S. Mylne, Herbicidal properties of antimalarial drugs, Sci. Rep, vol.7, 2017.

B. Coutard, A. E. Gorbalenya, E. J. Snijder, A. M. Leontovich, A. Poupon et al., The VIZIER project: preparedness against pathogenic RNA viruses, Antivir. Res, vol.78, pp.37-46, 2008.

S. Crotty, D. Maag, J. J. Arnold, W. Zhong, J. Y. Lau et al., The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen, Nat. Med, vol.6, pp.1375-1379, 2000.

L. Dacheux, S. Wacharapluesadee, T. Hemachudha, F. Meslin, P. Buchy et al., More accurate insight into the incidence of human rabies in developing countries through validated laboratory techniques, PLoS Neglected Trop. Dis. 4, e765, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-00596365

P. De-benedictis, A. Minola, E. Rota-nodari, R. Aiello, B. Zecchin et al., Development of broad-spectrum human monoclonal antibodies for rabies postexposure prophylaxis, EMBO Mol. Med, vol.8, issue.4, p.407, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01429575

O. Delmas, E. C. Holmes, C. Talbi, F. Larrous, L. Dacheux et al., Genomic diversity and evolution of the lyssaviruses, PloS One, vol.3, 2008.

C. Deng, H. Yeo, H. Ye, S. Liu, B. Shang et al., Inhibition of enterovirus 71 by adenosine analog NITD008, J. Virol, vol.88, pp.11915-11923, 2014.

B. Dodet, The fight against rabies in Africa: from recognition to action, Africa Rabies Bureau (AfroREB), vol.27, pp.5027-5032, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-01491973

L. Dufkova, J. Sirmarova, J. Salat, V. Honig, M. Palus et al., Mannitol treatment is not effective in therapy of rabies virus infection in mice, 2017.

T. P. Eisele, D. A. Larsen, P. A. Anglewicz, J. Keating, J. Yukich et al., Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa, Lancet Infect. Dis, vol.12, pp.942-949, 2012.

S. Fernandes, E. Sicuri, K. Kayentao, A. M. Van-eijk, J. Hill et al., Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data, Lancet Glob. Health, vol.3, pp.70385-70392, 2015.

A. R. Fooks, F. Cliquet, S. Finke, C. Freuling, T. Hemachudha et al., Rabies. Nat. Rev. Dis. Primers, vol.3, p.17091, 2017.

J. Friesen, S. Borrmann, and K. Matuschewski, Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistance, Antimicrob. Agents Chemother, vol.55, pp.2760-2767, 2011.

A. Ghanem, A. Kern, and K. Conzelmann, Significantly improved rescue of rabies virus from cDNA plasmids, Eur. J. Cell Biol, vol.91, pp.10-16, 2012.

K. Hampson, L. Coudeville, T. Lembo, M. Sambo, A. Kieffer et al., Global Alliance for Rabies Control Partners for Rabies Prevention, PLoS Negl. Trop. Dis, vol.9, 2015.

T. Hemachudha, B. Sunsaneewitayakul, T. Desudchit, C. Suankratay, C. Sittipunt et al., Failure of therapeutic coma and ketamine for therapy of human rabies, J. Neurovirol, vol.12, pp.407-409, 2006.

J. E. Hyde, Targeting purine and pyrimidine metabolism in human apicomplexan parasites, Curr. Drug Targets, vol.8, pp.31-47, 2007.

A. C. Jackson, Current and future approaches to the therapy of human rabies, Antivir. Res, vol.99, pp.61-67, 2013.

A. C. Jackson, Is minocycline useful for therapy of acute viral encephalitis?, Antivir. Res, vol.95, pp.242-244, 2012.

C. J. Janse, J. Ramesar, and A. P. Waters, High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei, Nat. Protoc, vol.1, pp.346-356, 2006.

K. Kayentao, P. Garner, A. M. Van-eijk, I. Naidoo, C. Roper et al., Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis, JAMA, vol.309, pp.594-604, 2013.

M. Lucas-hourani, D. Dauzonne, P. Jorda, G. Cousin, A. Lupan et al., Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity, PLoS Pathog, vol.9, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-01113535

A. Marosi, L. Dufkova, B. Forró, O. Felde, K. Erdélyi et al., Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin, 2018.

R. Mcleod, D. Mack, R. Foss, K. Boyer, S. Withers et al., Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. toxoplasmosis study group, Antimicrob. Agents Chemother, vol.36, pp.1040-1048, 1992.

W. Phoolcharoen, A. C. Banyard, C. Prehaud, D. Selden, G. Wu et al., In vitro and in vivo evaluation of a single chain antibody fragment generated in planta with potent rabies neutralisation activity, 2018.

F. Ribadeau-dumas, F. Cliquet, P. Gautret, E. Robardet, C. Le-pen et al., Travel-associated rabies in pets and residual rabies risk, Western Europe. Emerg. Infect. Dis, vol.22, pp.1268-1271, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01429541

A. Santos, E. Cale, L. Dacheux, H. Bourhy, J. Gouveia et al., Fatal case of imported human rabies in Amadora, Portugal, Euro Surveill. Bull. Eur. Sur Mal. Transm. Eur. Commun. Dis. Bull, vol.17, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-01481640

P. Shantavasinkul and H. Wilde, Postexposure prophylaxis for rabies in resourcelimited/poor countries, Adv. Virus Res, vol.79, pp.291-307, 2011.

M. Smreczak, A. Or?owska, A. Marzec, P. Tr?bas, A. Kycko et al., The effect of combined drugs therapy on the course of clinical rabies infection in a murine model, 2018.

N. J. Stevenson, A. G. Murphy, N. M. Bourke, C. A. Keogh, J. E. Hegarty et al., Ribavirin enhances IFN-? signalling and MxA expression: a novel immune modulation mechanism during treatment of HCV, PloS One, vol.6, 2011.

F. Superti, L. Seganti, A. Pana, and N. Orsi, Effect of amantadine on rhabdovirus infection, Drugs Exp. Clin. Res, vol.11, issue.1, 1985.

A. Takakura, E. A. Nelson, N. Haque, B. D. Humphreys, K. Zandi-nejad et al., Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways, Hum. Mol. Genet, vol.20, pp.4143-4154, 2011.

R. C. Tam, J. Y. Lau, and Z. Hong, Mechanisms of action of ribavirin in antiviral therapies, Antivir. Chem. Chemother, vol.12, pp.261-272, 2001.

F. O. Ter-kuile, A. M. Van-eijk, and S. J. Filler, Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review, JAMA, vol.297, pp.2603-2616, 2007.

P. Thongcharoen, P. Sureau, C. Wasi, H. Bourhy, P. Chaiprasithikul et al., Monoclonal antibody studies of rabies viruses isolated from Thailand, Southeast Asian J. Trop. Med. Public Health, vol.21, pp.129-133, 1990.

Y. Tokumoto, Y. Hiasa, K. Uesugi, T. Watanabe, T. Mashiba et al., Ribavirin regulates hepatitis C virus replication through enhancing interferon-stimulated genes and interleukin 8, J. Infect. Dis, vol.205, pp.1121-1130, 2012.

P. G. Walker, F. O. Ter-kuile, T. Garske, C. Menendez, and A. C. Ghani, Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study, Lancet Glob. Health, vol.2, pp.70256-70262, 2014.

Z. W. Wang, L. Sarmento, Y. Wang, X. Li, V. Dhingra et al., Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system, J. Virol, vol.79, pp.12554-12565, 2005.

M. J. Warrell, N. J. White, S. Looareesuwan, R. E. Phillips, P. Suntharasamai et al., Failure of interferon alfa and tribavirin in rabies encephalitis, BMJ, vol.299, pp.830-833, 1989.

L. M. Weiss, C. Harris, M. Berger, H. B. Tanowitz, and M. Wittner, Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS, J. Infect. Dis, vol.157, pp.580-583, 1988.

, Human rabies: 2016 updates and call for data, 2017.

H. Wilde and B. Lumlertdacha, Rabies research in resource-poor countries, Adv. Virus Res, vol.79, pp.449-455, 2011.

R. E. Willoughby and A. L. Hammarin, Prophylaxis against rabies in children exposed to bats, Pediatr. Infect. Dis. J, vol.24, issue.12, 2005.

L. Wiltzer, F. Larrous, S. Oksayan, N. Ito, G. A. Marsh et al., Conservation of a unique mechanism of immune evasion across the Lyssavirus genus, J. Virol, vol.86, pp.1249-1261, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-01481638

K. Yamada, K. Noguchi, T. Komeno, Y. Furuta, and A. Nishizono, Efficacy of Favipiravir (T-705) in rabies postexposure prophylaxis, J. Infect. Dis, vol.213, pp.1253-1261, 2016.

L. C. Yeh, M. C. Zavala, and J. C. Lee, C-type natriuretic peptide enhances osteogenic protein-1-induced osteoblastic cell differentiation via Smad5 phosphorylation, J. Cell. Biochem, vol.97, pp.494-500, 2006.

K. L. Yeo, Y. Chen, H. Y. Xu, H. Dong, Q. Wang et al., Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors, Antimicrob. Agents Chemother, vol.59, pp.2086-2093, 2015.